SLU-PP-332

ERRs (often referenced as ERRα, ERRβ, and ERRγ) are transcription-regulating receptors that influence how cells coordinate energy-demand pathways, including mitochondrial-associated gene networks. SLU-PP-332 is frequently discussed as a potent but non-selective ERR agonist with strongest activity reported at ERRα in vitro, making it a useful tool for comparative receptor studies and pathway mapping.
Common research characteristics:

• Compound type: Synthetic small molecule (research compound)
• Primary targets studied: ERRα / ERRβ / ERRγ (non-selective agonist profile)
• Research focus: Nuclear receptor signaling, transcriptional regulation, mitochondrial-related gene programs
• Use setting: Controlled in vitro assays and non-clinical research models

SLU-PP-332 is primarily used to study ERR-mediated signaling and the downstream transcriptional programs ERRs coordinate. Because ERR pathways intersect with cellular energy regulation, researchers often use SLU-PP-332 in mechanistic work where gene-expression shifts and pathway outputs can be measured directly.

Common research themes include:

• Receptor pharmacology: Evaluating agonist activity across ERR subtypes, selectivity comparisons, and target-engagement behavior in receptor-based assay panels.
• Transcription and gene-expression studies: Measuring changes in ERR-regulated gene markers using reporter assays, qPCR panels, RNA sequencing, or protein-expression workflows.
• Mitochondrial and energy-pathway models: Exploring how ERR activation correlates with mitochondrial-associated transcriptional signatures and cellular energy-demand responses in controlled experimental conditions.
• Exercise-associated signaling research (non-clinical): Using SLU-PP-332 as a pathway probe in models designed to examine transcriptional programs that overlap with exercise-adaptation signaling (research context only; no outcomes implied).
• Off-target and pathway specificity checks: Designing experiments to differentiate ERR-driven effects from estrogen receptor–mediated pathways, since ERRs are distinct targets that require careful assay controls.

Q1: What is SLU-PP-332?
A1: SLU-PP-332 is a synthetic research compound studied as an agonist of estrogen-related receptors (ERRα/ERRβ/ERRγ) for laboratory investigations into nuclear receptor signaling.

Q2: Is SLU-PP-332 a peptide?
A2: SLU-PP-332 is generally described as a small molecule, not a peptide. It’s used in research settings to modulate ERR signaling pathways.

Q3: What are ERRs, and why are they studied?
A3: Estrogen-related receptors (ERRs) are nuclear receptors that regulate gene expression. Researchers study them because they influence transcriptional programs linked to cellular energy regulation and mitochondrial-associated pathways.

Q4: What types of experiments use SLU-PP-332?
A4: Common uses include receptor reporter assays, gene-expression profiling (qPCR/RNA-based methods), target engagement studies, and pathway mapping in ERR-focused research models.

Q5: How should SLU-PP-332 be stored?
A5: Store sealed and protected from light and moisture according to your lab’s SOP. Many labs use controlled-temperature storage and minimize repeated temperature cycling.